NIVF

NIVF Stock Forecast: NewGenIVF Group Ltd. Price Predictions for 2026-2027

Last close, 31 July 2026

$0.81

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 13 of 100 as at 1 Aug 2026 — in the weakest quartile.

Market cap

—

Ticker Nerd rank

13 / 100

Median analyst target

—

Analysts covering

—

Ticker Nerd rank

NIVF stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores NewGenIVF Group Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Aug 2026

13 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size

Revisions

Growth

Value

Quality

Momentum

Accruals

Volatility

Issuance

Size (98): Smaller than most of the companies we track.

Issuance (6): The company has been issuing shares or taking on financing, diluting existing holders.

The rank is the raw material. Whether the rules would actually own NewGenIVF Group Ltd. — and when they’d sell — is the membership.

Wall Street

NIVF stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on NIVF, reported as data — targets and ratings, the market's view beside the model's.

We don’t hold enough price history for this company yet.

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

NIVF analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

NewGenIVF Group Ltd. (NIVF) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: —
Price / sales: —
Price / book: —
EV / EBITDA: —

Growth & margins

Revenue growth (YoY): —
Earnings growth (YoY): —
Gross margin: —
Operating margin: —
Net margin: —

Returns & dividend

Return on equity: —
Return on assets: —
Dividend yield: —

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

NIVF vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. NIVF appears on the weeks it earns a place.

News

Latest NIVF news & analysis

NewGen Provides Update on K25.ai Investment and Strengthened Financial Position

GlobeNewsWire · 30 July 2026positive

NewGenIVF reported that its 13% stake in K25.ai is now valued at approximately US$26 million following K25.ai's Series A round, representing an unrealized gain of about US$8.5 million. The company also disclosed a net profit of US$9.9 million for fiscal 2025 and expects total shares outstanding to reach 5.9 million after a recently announced share issuance.

Why it matters — NIVF watchers would care because this update provides confirmation of the increased valuation of the K25.ai investment and a clearer picture of the company's strengthened capitalization and financial position.

NewGen to Acquire Additional 3% of K25.ai at US$250 Million Valuation Following Strong Community Beta; Strengthening Market Cap Above US$5 Million

GlobeNewsWire · 27 July 2026positive

NewGen IVF Group Ltd. plans to acquire an additional 3% stake in K25.ai at a US$250 million valuation, following a strong community beta, which would increase its aggregate ownership to 13% and strengthen its market cap above US$5 million.

Why it matters — A NIVF watcher would care because this follow-on investment signals NewGen's deepening commitment to AI and could meaningfully boost the company's valuation and growth narrative.

FAQ

Frequently asked questions about NIVF stock

How does Ticker Nerd's model rank NIVF?

As at 1 Aug 2026, NewGenIVF Group Ltd. ranks 13 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (98 of 100).

What is the NIVF stock forecast for 2030?

No analyst covering NewGenIVF Group Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NIVF are extrapolating price history, which says nothing about the business.

What is the latest news on NIVF?

The most recent item we track (GlobeNewsWire, 30 July 2026): "NewGen Provides Update on K25.ai Investment and Strengthened Financial Position". NewGenIVF reported that its 13% stake in K25.ai is now valued at approximately US$26 million following K25.ai's Series A round, representing an unrealized gain of about US$8.5 million. The company also disclosed a net profit of US$9.9 million for fiscal 2025 and expects total shares outstanding to reach 5.9 million after a recently announced share issuance.